WaveTec Vision Systems, Inc. – Trademark Portfolio
Entity Type: 03
WaveTec Vision Systems, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include VERIFEYE and ORA SYSTEM. The owner is based in Aliso Viejo, CA.
Suite 170
66 Argonaut
Aliso Viejo, CA 92656
Showing of trademarks Trademarks
Trademark Classifications
WaveTec Vision Systems, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does WaveTec Vision Systems, Inc. have?
WaveTec Vision Systems, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 6 cancelled.
What trademark classes does WaveTec Vision Systems, Inc. file in?
WaveTec Vision Systems, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are WaveTec Vision Systems, Inc.'s most well-known trademarks?
WaveTec Vision Systems, Inc.'s registered trademark portfolio includes well-known marks such as VERIFEYE and ORA SYSTEM. These are among 2 currently registered trademarks in the portfolio.
What is WaveTec Vision Systems, Inc.'s trademark registration success rate?
WaveTec Vision Systems, Inc. has a 20% trademark registration rate, with 2 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.